Medios AG
Wholesale and manufacturing of specialty pharmaceuticals for complex and rare diseases.
ILM1 | F
Overview
Corporate Details
- ISIN(s):
- DE000A1MMCC8 (+1 more)
- LEI:
- 391200Z7Z09IHDBT2L23
- Country:
- Germany
- Address:
- Heidestraße 9, 10557 Berlin
- Website:
- https://medios.ag/en/
- Sector:
- Manufacturing
Description
Medios AG is a specialty pharmaceutical company focused on providing solutions for complex and rare diseases. The company's core business encompasses two main segments: the wholesale distribution of specialty pharma drugs and the manufacturing of patient-specific therapies. The manufacturing division compounds personalized medications, such as sterile infusions, for individual patients. As a comprehensive partner, Medios covers critical aspects of the supply chain for specialized pharmacies, medical practitioners, and pharmaceutical companies. The company is also dedicated to advancing individualized medicine by pioneering biotechnological precision medicine and advanced therapies to provide patients with innovative treatments.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2024-06-11 13:34 |
Release according to Article 41 of the WpHG [the German Securities Trading Act]…
|
English | 4.4 KB | ||
| 2024-06-07 10:28 |
Hauck & Aufhauser starts coverage of Medios AG with buy recommendation and pric…
|
English | 7.2 KB | ||
| 2024-06-06 11:32 |
Medios AG successfully completes acquisition of Ceban, significantly expanding …
|
English | 8.9 KB | ||
| 2024-05-07 07:31 |
Medios AG records further revenue growth in the first quarter of 2024 and confi…
|
English | 21.6 KB | ||
| 2024-05-07 00:00 |
Q1 statement / Q1 financial report 2024
|
English | 4.9 MB | ||
| 2024-05-06 14:19 |
Medios AG: Constantijn van Rietschoten appointed Executive Board member for Int…
|
English | 22.6 KB | ||
| 2024-03-27 07:54 |
Medios achieves double-digit growth in 2023 Positive outlook for 2024
|
English | 18.1 KB | ||
| 2024-03-27 00:00 |
Jahresfinanzbericht 2023 (PDF)
|
German | 5.6 MB | ||
| 2024-03-27 00:00 |
Annual financial report 2023 (PDF)
|
English | 5.4 MB | ||
| 2024-03-18 20:46 |
Medios acquires Dutch market leader in pharmaceutical compounding services
|
English | 19.4 KB | ||
| 2024-03-18 20:41 |
Medios acquires Dutch market leader in pharmaceutical compounding services
|
English | 11.2 KB | ||
| 2024-02-14 12:30 | English | 14.0 KB | |||
| 2024-02-02 15:30 | English | 13.9 KB | |||
| 2024-02-01 10:46 |
Medios AG: Supervisory Board extends contracts with members of the Executive Bo…
|
English | 9.9 KB | ||
| 2023-12-21 15:15 | English | 14.0 KB |
Automate Your Workflow. Get a real-time feed of all Medios AG filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for Medios AG
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for Medios AG via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| 2024-08-19 | van Rietschoten, Constantijn | Board | Buy | None | 162,805.82 EUR |
| 2023-06-28 | Prußeit, Christoph | Board | Buy | None | 39,100.00 EUR |
| 2021-12-09 | Miehler, Mi-Young | Board | Other | None | 3,550,000.00 EUR |
| 2021-12-09 | Prußeit, Christoph | Board | Other | None | 1,775,000.00 EUR |
| 2021-12-09 | Miehler, Mi-Young | Board | Other | None | 700,000.00 EUR |
| 2021-12-09 | Prußeit, Christoph | Board | Other | None | 350,000.00 EUR |
Peer Companies
